Galderma Holding SA, headquartered in Zug, Switzerland, specializes in dermatological treatments, focusing on innovative solutions for skin health. The company is known for its advancements in areas such as prurigo nodularis, JAK inhibitors, and hyaluronic acid formulations. Galderma also develops esthetic compositions, including botulinum toxin products and hydrogel applications, aimed at addressing various skin lesions and enhancing patient outcomes. Its commitment to research and development positions it as a leader in the dermatology field.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

65 Patents

#15 in Zug

#234 in Switzerland

#11,332 in the World

Zug, Switzerland

Galderma Holding Sa

Forward Citations = 108

80 inventors:

Johan Olsson (14 out of 15 patents)

Craig Steven Harris (13 out of 18 patents)

Oscar Ullsten (10 out of 10 patents)

4. Morgan Karlsson (9 out of 12 patents)

5. Oliver Tyrsing (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Galderma Holding Sa. Retrieved from https://idiyas.com/company/galderma-holding-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

11 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]